Abstract
Nonhuman primates provide the ideal animal model for discovering and examining further the mechanisms underlying human type 2 diabetes mellitus. In all aspects studied to date the nonhuman primate has been shown to develop the same disease with the same features that develop in overweight middle-aged humans. This includes the progressive development of the known complications of diabetes, all of which are extraordinarily like those identified in humans. In addition, for the development and evaluation of new therapeutic agents, the translation of findings from nonhuman primates to application in humans has been highly predictable. Both therapeutic efficacy and identification of potential adverse responses can be effectively examined in nonhuman primates due to their great similarity to humans at the molecular, biochemical, and physiological levels. This chapter provides guidance for the development and management of a colony of monkeys with naturally occurring type 2 diabetes mellitus.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hansen BC, Bodkin NL (1986) Heterogeneity of insulin responses: phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey. Diabetologia 29:713–719
Hansen BC, Bodkin NL (1990) Beta-cell hyperresponsiveness: earliest event in development of diabetes in monkeys. Am J Physiol 259:R612–R617
Ortmeyer HK, Bodkin NL, Hansen BC (1993) Insulin-mediated glycogen synthase activity in muscle of spontaneously insulin-resistant and diabetic rhesus monkeys. Am J Physiol 265:R552–R558
Hotta K, Funahashi T, Bodkin NL et al (2001) Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50:1126–1133
Bodkin NL, Alexander TM, Ortmeyer HK et al (2003) Mortality and morbidity in laboratory-maintained Rhesus monkeys and effects of long-term dietary restriction. J Gerontol A Biol Sci Med Sci 58:212–219
Tigno XT, Gerzanich G, Hansen BC et al (2004) Age-related changes in metabolic parameters of nonhuman primates. J Gerontol A Biol Sci Med Sci 59:1081–1088
Ding SY, Tigno XT, Hansen BC et al (2007) Nuclear magnetic resonance-determined lipoprotein abnormalities in nonhuman primates with the metabolic syndrome and type 2 diabetes mellitus. Metabolism 56:838–846
Cnop M, Hughes SJ, Igoillo-Esteve M et al (2010) The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia 53:321–330
Cusumano AM, Bodkin NL, Hansen BC et al (2002) Glomerular hypertrophy is associated with hyperinsulinemia and precedes overt diabetes in aging rhesus monkeys. Am J Kidney Dis 40:1075–1085
Bauer SA, Leslie KE, Pearl DL et al (2010) Survey of prevalence of overweight body condition in laboratory-housed cynomolgus macaques (Macaca fascicularis). J Am Assoc Lab Anim Sci 49:407–414
Bauer SA, Leslie KE, Pearl DL et al (2010) Retrospective case–control study of hyperglycemia in group-housed, mature female cynomolgus macaques (Macaca fascicularis). J Med Primatol 39:408–416
Chavez AO, Lopez-Alvarenga JC, Tejero ME et al (2008) Physiological and molecular determinants of insulin action in the baboon. Diabetes 57:899–908
Guardado-Mendoza R, Dick EJ Jr, Jimenez-Ceja LM et al (2009) Spontaneous pathology of the baboon endocrine system. J Med Primatol 38:383–389
Perez VL, Caicedo A, Berman DM et al (2011) The anterior chamber of the eye as a clinical transplantation site for the treatment of diabetes: a study in a baboon model of diabetes. Diabetologia 54:1121–1126
McTighe MS, Hansen BC, Ely JJ et al (2011) Determination of hemoglobin A1c and fasting blood glucose reference intervals in captive chimpanzees (Pan troglodytes). J Am Assoc Lab Anim Sci 50(2):165–170
Winegar DA, Brown PJ, Wilkison WO et al (2001) Effects of fenofibrate on lipid parameters in obese rhesus monkeys. J Lipid Res 42(10):1543–1551
Schafer SA, Hansen BC, Völkl A et al (2004) Biochemical and morphological effects of K-111, a peroxisome proliferator-activated receptor (PPAR) alpha activator, in non-human primates. Biochem Pharmacol 68:239–251
Ding SY, Tigno XT, Braileanu GT et al (2007) A novel peroxisome proliferator–activated receptor alpha/gamma dual agonist ameliorates dyslipidemia and insulin resistance in prediabetic rhesus monkeys. Metabolism 56:1334–1339
Kharitonenkov A, Wroblewski VJ, Koester A et al (2007) The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 148:774–781
Kavanagh K, Brown KK, Berquist ML et al (2010) Fluid compartmental shifts with efficacious pioglitazone therapy in overweight monkeys: implications for peroxisome proliferator-activated receptor-gamma agonist use in prediabetes. Metabolism 59:914–920
Wagner JD, Shadoan MK, Zhang L et al (2010) A selective peroxisome proliferator-activated receptor alpha agonist, CP-900691, improves plasma lipids, lipoproteins, and glycemic control in diabetic monkeys. J Pharmacol Exp Ther 333:844–853
Hansen BC, Tigno XT, Bénardeau A et al (2011) Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor alpha/gamma agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome. Cardiovasc Diabetol 10:7
Casu A, Bottino R, Balamurugan AN et al (2008) Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: implications for translation into clinical practice. Diabetologia 51:120–129
Bottino R, Criscimanna A, Casu A et al (2009) Recovery of endogenous beta-cell function in nonhuman primates after chemical diabetes induction and islet transplantation. Diabetes 58(2):442–447
Rogers SA, Mohanakumar T, Liapis H et al (2010) Engraftment of cells from porcine islets of Langerhans and normalization of glucose tolerance following transplantation of pig pancreatic primordia in nonimmune-suppressed diabetic rats. Am J Pathol 177:854–864
Hammerman MR (2011) Engraftment of insulin-producing cells from porcine islets in non-immune-suppressed rats or nonhuman primates transplanted previously with embryonic pig pancreas. J Transplant 2011:261352
Kim SY, Johnson MA, McLeod DS et al (2005) Neutrophils are associated with capillary closure in spontaneously diabetic monkey retinas. Diabetes 54:1534–1542
Pare M, Albrecht PJ, Noto CJ et al (2007) Differential hypertrophy and atrophy among all types of cutaneous innervation in the glabrous skin of the monkey hand during aging and naturally occurring type 2 diabetes. J Comp Neurol 501:543–567
Najafian B, Masood A, Malloy PC et al (2011) Glomerulopathy in spontaneously obese rhesus monkeys with type 2 diabetes: a stereological study. Diabetes Metab Res Rev 27:341–347
National Research Council (2011) Guide for the care and use of laboratory animals, 8th edn. The National Academies Press, Washington, DC
Tigno XT, Ding SY, Hansen BC (2006) Paradoxical increase in dermal microvascular flow in pre-diabetes associated with elevated levels of CRP. Clin Hemorheol Microcirc 34:273–282
Tigno XT, Hansen BC, Nawang S et al (2011) Vasomotion becomes less random as diabetes progresses in monkeys. Microcirculation 18:429–439
Shamekh R, Linden EH, Newcomb JD et al (2011) Endogenous and diet-induced hypercholesterolemia in nonhuman primates: effects of age, adiposity, and diabetes on lipoprotein profiles. Metabolism 60:1165–1177
Hansen BC, Bodkin NL (1993) Primary prevention of diabetes mellitus by prevention of obesity in monkeys. Diabetes 42:1809–1814
Ortmeyer HK, Sajan MP, Miura A et al (2011) Insulin signaling and insulin sensitizing in muscle and liver of obese monkeys: peroxisome proliferator-activated receptor gamma agonist improves defective activation of atypical protein kinase C. Antioxid Redox Signal 14:207–219
Kemnitz JW, Elson DF, Roecker EB, et al (1994) Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys. Diabetes 43:204–211
Acknowledgments
This work was supported by NIH grants and contracts including NIA HHSN253200800C and NIA N01AG31012 and by past support from various foundations and industry. The extraordinary quality of care was based on the work of Drs. Noni Bodkin, Heidi Ortmeyer, and Cathy Kai-Lin Jen. The work on the complications of diabetes has had many critical collaborators and coworkers, Âparticularly the dedicated efforts of Dr. Xenia Tigno.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Hansen, B.C. (2012). Investigation and Treatment of Type 2 Diabetes in Nonhuman Primates. In: Joost, HG., Al-Hasani, H., Schürmann, A. (eds) Animal Models in Diabetes Research. Methods in Molecular Biology, vol 933. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-068-7_11
Download citation
DOI: https://doi.org/10.1007/978-1-62703-068-7_11
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-067-0
Online ISBN: 978-1-62703-068-7
eBook Packages: Springer Protocols